Targeting Toll-like receptor 4 with CLI-095 (TAK-242) enhances the antimetastatic effect of the estrogen receptor antagonist fulvestrant on non-small cell lung cancerFrank S. Fan, Bo Ai|Clinical & Translational Oncology|2020Cited by 9
Targeting Toll-like receptor 4 with CLI-095 (TAK-242) enhances the antimetastatic effect of the estrogen receptor antagonist fulvestrant on non-small cell lung cancerFrank S. Fan, Bo Ai|Research Square|2019Cited by 2